Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
January 8,2021
Celularity Inc. is a clinical-stage biotechnology company, and leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived...
ShortCut Device Used to Treat a Patient Reported a Success
ShortCut is the world’s first dedicated device designed to split the leaflets of a pre-existing valve to enable safe Transcatheter Aortic Valve Replacement in patients at risk for coronary obstruction or compromised coronary access.
Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
QUEST is a 180-subject, randomized, double blinded, active sham controlled clinical trial that is being conducted under an Investigational Device Exemption
Neuros Medical Raises $38.5M in Series BB: Funds Enable Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
The financing provides capital to complete enrollment of the pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study, and to submit an anticipated application for Pre-Market Approval. QUEST is a 180-subject, randomized, double-blinded, active sham-controlled clinical trial that is being conducted under an Investigational Device Exemption
Fallon Health Partners With RX Savings Solutions
Fallon is the first health plan in the region to launch the patented solution to a Medicare Advantage population. Rx Savings Solutions connects securely with a member's drug claim records and prepares a personalized prescription savings plan.